Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Pandoraon Jun 18, 2021 8:31pm
221 Views
Post# 33415798

RE:From about a year ago...

RE:From about a year ago...
Ticklel1st wrote:
Kingkoi (4) | July 29, 2020 12:42 am

During the last year, management gave themselves a bonus of $260,000 as follows:

Howard: $94,000
Chris: $74,000
Graldine: $39,000
Michelle: $53,000
Total: $260,000

They took $150,000 in bonus in June 2019 in connection with the R+F transaction. On top of that they granted themselves $110,000 in bonuses in March 2019 (see the audited financial statements page 31 and 32 note a) through e).

It also appears that Jason Tian got $46,000 in directors fees/bonuses on top of the $150,000 (see page 31 note b).

Who are on the compensation committee? This seems a bit excessive, no?


Who are on the compensation committee? Possibly Howard, Chris, Geraldine and Michelle. :-))
<< Previous
Bullboard Posts
Next >>